Mereyim Bouslikhane
Accepted Abstracts: Pharmaceut Reg Affairs
Government, pharmacists, physicians, patients and health insurance companies are interested in safe and efficient product and asking value for money; the reason that pharmaceutical companies have the obligation to validate their processes to meet GMP requirements. The validation is a fundamental part of regulatory requirements for almost every process in the global health industry (Pharmaceuticals, biologics and medical devices); it is a key component in assuring that the quality targets are met. This presentation will give a general overview on the validation activities and highlight its impact on the pharmaceutical industry to ensure that systems, services and products directly influenced by the testing have been identified.
Mereyim Bouslikhane Holds a Ph.D. in organic chemistry from the University of Paul Sabatier in France and completed a postdoctoral in the field of anti-diabetics molecules synthesis. She has experience in Quality and Regulatory Affairs for the GCC, Levant, Africa & CIS countries and currently involved in validation activities at Neopharma, Abu Dhabi, United Arab Emirates.
Pharmaceutical Regulatory Affairs: Open Access received 533 citations as per Google Scholar report
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 